Related references
Note: Only part of the references are listed.Multiple Sclerosis
Ardith M. Courtney et al.
MEDICAL CLINICS OF NORTH AMERICA (2009)
Compliance, adherence, and the treatment of multiple sclerosis
Thomas Klauer et al.
JOURNAL OF NEUROLOGY (2008)
Disease-modifying therapy in multiple sclerosis Update and clinical implications
Douglas S. Goodin
NEUROLOGY (2008)
Long-term adherence to interferon beta therapy in relapsing-remitting multiple sclerosis
E. Portaccio et al.
EUROPEAN NEUROLOGY (2008)
Predicting ongoing adherence to disease modifying therapies in multiple sclerosis: utility of the health beliefs model
A. P. Turner et al.
MULTIPLE SCLEROSIS (2007)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Evaluation of software-based telephone Counseling to enhance medication persistency among patients with multiple sclerosis
Bruce A. Berger et al.
JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2005)
Factors related with treatment adherence to interferon β and glatiramer acetate therapy in multiple sclerosis
L Río et al.
MULTIPLE SCLEROSIS (2005)
Twenty-four-month comparison of immunomodulatory treatments -: a retrospective open label study in 308 RRMS patients treated with beta interferons or glatiramer acetate (Copaxone®)
J Haas et al.
EUROPEAN JOURNAL OF NEUROLOGY (2005)
Stopping beta-interferon therapy in multiple sclerosis: an analysis of stopping patterns
KET O'Rourke et al.
MULTIPLE SCLEROSIS JOURNAL (2005)
Interrupted therapy -: Stopping and switching of the β-interferons prescribed for MS
HL Tremlett et al.
NEUROLOGY (2003)
A post-marketing study on interferon beta 1b and 1a treatment in relapsing-remitting multiple sclerosis: different response in drop-outs and treated patients
C Milanese et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2003)
Long-term interferon-beta treatment for multiple sclerosis
RM Ruggieri et al.
NEUROLOGICAL SCIENCES (2003)
Injectable medication for the treatment of multiple sclerosis: The influence of self-efficacy expectations and injection anxiety on adherence and ability to self-inject
DC Mohr et al.
ANNALS OF BEHAVIORAL MEDICINE (2001)
Share Paper
